Treatment of gastric outlet and duodenal obstructions with uncovered expandable metal stents

Table 1 Patient information

Case	Sex/age (yr)	Underlying disease	Stent size (diameter × length, mm)	Duration of oral intake after stenting	Follow-up time	Outcome
1	F/68	Ampullary cancer	22 × 90	At least 10 d	10 d
2	M/72	Gastric cancer	22 × 60	15 d	24 d	Dead
3	F/39	Pancreatic cancer	20 × 90	At least 4 mo	4 mo
4	F/65	Pancreatic cancer	22 × 90	38 d	74 d	Dead
5	M/86	Pancreatic cancer	20 × 90	80 d	85 d	Dead
6	M/87	Pancreatic cancer	20 × 60	At least 20 d	20 d
			22 × 60
7	M/80	Ampullary cancer	20 × 60	9 mo	10 mo	Dead
8	F/72	Colon cancer	22 × 90	22 d	26 d	Dead
			22 × 60
9	M/66	Gallbladder cancer	22 × 90	7 d	50 d	Dead
10	M/33	Acute necrotizing pancreatitis	20 × 60		1 y
			22 × 60
			22 × 90
11	M/67	Duodenal cancer	20 × 90	60 d	70 d	Dead
12	M/68	Pancreatic cancer	20 × 90	7 d	10 d	Dead
13	M/48	Pancreatic cancer	20 × 90	0 d	6 d	Dead
14	M/32	Colon cancer	20 × 60	At least 7 d	7 d
15	M/53	Esophageal cancer	20 × 60	0 d	40 d	Dead